Wealth Enhancement Advisory Services, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 7,052 shares of RARE stock, worth $266,706. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,052
Previous 22,047
68.01%
Holding current value
$266,706
Previous $927,000
68.07%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
84.3MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$380 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$212 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$163 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$103 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$95 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.65B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...